• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RIPK2 介导的 NOD1 信号激活通过 NF-κB 通路促进卵巢癌细胞的增殖和侵袭。

Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.

机构信息

Obstetrics and Gynecology Department, The First Affiliated Hospital of JinZhou Medical University, No. 2, Section 5, Renmin Street, JinZhou City, 121000, LiaoNing Province, China.

出版信息

Histochem Cell Biol. 2022 Feb;157(2):173-182. doi: 10.1007/s00418-021-02055-z. Epub 2021 Nov 26.

DOI:10.1007/s00418-021-02055-z
PMID:34825931
Abstract

The goal of this study was to investigate the role and mechanism of action of nucleotide oligomerization domain receptor 1 (NOD1) in ovarian cancer. Results showed that the expressions of NOD1 and receptor interacting serine/threonine kinase 2 (RIPK2) were notably upregulated in non-metastatic and metastatic ovarian tumors compared with matched non-tumor tissues, and their expression in metastatic tumor tissues was higher than that in non-metastatic tumors. Overexpression of NOD1 facilitated the expression of proliferation-related proteins (PCNA and Ki67) and proliferation and invasion of ovarian cancer cells. Overexpression of NOD1 promoted NF-κB expression and phosphorylation. Importantly, NOD1 bound with RIPK2, and silencing of RIPK2 partly rescued the promotion of NOD1 to NF-κB expression and its phosphorylation. The promotion of NOD1 to ovarian cancer cell proliferation and invasion was partly reversed by RIPK2 silencing. Results from our in vivo study indicate that overexpression of NOD1 accelerated the growth of ovarian cancer tumors, expression of proliferation-related proteins, and activation of NF-κB. However, silencing of NOD1 suppressed tumor growth. In summary, NOD1 facilitates ovarian cancer progression by activating NF-κB signaling by binding to RIPK2. We suggest a new strategy for the treatment of ovarian cancer.

摘要

本研究旨在探讨核苷酸寡聚化结构域受体 1(NOD1)在卵巢癌中的作用和机制。结果表明,与匹配的非肿瘤组织相比,非转移性和转移性卵巢肿瘤中 NOD1 和受体相互作用丝氨酸/苏氨酸激酶 2(RIPK2)的表达明显上调,转移性肿瘤组织中的表达高于非转移性肿瘤。NOD1 的过表达促进了增殖相关蛋白(PCNA 和 Ki67)的表达以及卵巢癌细胞的增殖和侵袭。NOD1 的过表达促进了 NF-κB 的表达和磷酸化。重要的是,NOD1 与 RIPK2 结合,沉默 RIPK2 部分挽救了 NOD1 对 NF-κB 表达及其磷酸化的促进作用。沉默 RIPK2 部分逆转了 NOD1 对卵巢癌细胞增殖和侵袭的促进作用。体内研究结果表明,NOD1 的过表达加速了卵巢癌肿瘤的生长、增殖相关蛋白的表达和 NF-κB 的激活。然而,沉默 NOD1 抑制了肿瘤的生长。总之,NOD1 通过与 RIPK2 结合激活 NF-κB 信号通路促进卵巢癌的进展。我们为卵巢癌的治疗提供了一种新的策略。

相似文献

1
Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.RIPK2 介导的 NOD1 信号激活通过 NF-κB 通路促进卵巢癌细胞的增殖和侵袭。
Histochem Cell Biol. 2022 Feb;157(2):173-182. doi: 10.1007/s00418-021-02055-z. Epub 2021 Nov 26.
2
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway.具核梭杆菌通过 NOD1/RIPK2/NF-κB 通路促进食管鳞癌进展。
Cancer Lett. 2022 Apr 1;530:59-67. doi: 10.1016/j.canlet.2022.01.014. Epub 2022 Jan 14.
3
NLRC3-like 1 inhibits NOD1-RIPK2 pathway via targeting RIPK2.NLRC3 样蛋白 1 通过靶向 RIPK2 抑制 NOD1-RIPK2 通路。
Dev Comp Immunol. 2020 Nov;112:103769. doi: 10.1016/j.dci.2020.103769. Epub 2020 Jul 4.
4
NOD1 cooperates with HAX-1 to promote cell migration in a RIPK2- and NF-ĸB-independent manner.NOD1 通过与 HAX-1 相互作用,以 RIPK2 和 NF-κB 非依赖的方式促进细胞迁移。
FEBS J. 2023 Nov;290(22):5295-5312. doi: 10.1111/febs.16912. Epub 2023 Aug 1.
5
Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.核苷酸结合寡聚化结构域1(NOD1)及其变体在体外和体内对人巨细胞病毒控制中的作用。
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7818-E7827. doi: 10.1073/pnas.1611711113. Epub 2016 Nov 16.
6
Transcription of NOD1 and NOD2 and their interaction with CARD9 and RIPK2 in IFN signaling in a perciform fish, the Chinese perch, .NOD1 和 NOD2 的转录及其与 CARD9 和 RIPK2 在鲈形目鱼类中国鲈鱼 IFN 信号转导中的相互作用。
Front Immunol. 2024 Apr 23;15:1374368. doi: 10.3389/fimmu.2024.1374368. eCollection 2024.
7
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer.RIPK2 的高表达与浆液性卵巢癌对紫杉醇的耐药性相关。
J Ovarian Res. 2022 Apr 27;15(1):48. doi: 10.1186/s13048-022-00986-2.
8
RIPK2 promotes the progression of colon cancer by regulating BIRC3-mediated ubiquitination of IKBKG.RIPK2 通过调节 BIRC3 介导的 IKBKG 泛素化促进结肠癌的进展。
Exp Cell Res. 2023 Aug 1;429(1):113644. doi: 10.1016/j.yexcr.2023.113644. Epub 2023 May 19.
9
Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.受体相互作用丝氨酸/苏氨酸蛋白激酶 2 作为一个新的治疗靶点。
J Med Chem. 2023 Nov 9;66(21):14391-14410. doi: 10.1021/acs.jmedchem.3c00593. Epub 2023 Oct 19.
10
Role of nucleotide-binding oligomerization domain 1 (NOD1) in pericyte-mediated vascular inflammation.核苷酸结合寡聚化结构域 1(NOD1)在周细胞介导的血管炎症中的作用。
J Cell Mol Med. 2016 May;20(5):980-6. doi: 10.1111/jcmm.12804. Epub 2016 Feb 24.

引用本文的文献

1
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury.CMD-OPT模型能够发现一种强效且具有选择性的RIPK2抑制剂,作为治疗急性肝损伤的临床前候选药物。
Acta Pharm Sin B. 2025 Jul;15(7):3708-3724. doi: 10.1016/j.apsb.2025.05.003. Epub 2025 May 13.
2
Evaluation of pyroptosis-associated genes in endometrial cancer utilizing a 101-combination machine learning framework and multi-omics data.利用101组合机器学习框架和多组学数据评估子宫内膜癌中焦亡相关基因
Front Med (Lausanne). 2025 Jun 5;12:1590405. doi: 10.3389/fmed.2025.1590405. eCollection 2025.
3

本文引用的文献

1
Knockdown of RIPK2 Inhibits Proliferation and Migration, and Induces Apoptosis the NF-κB Signaling Pathway in Gastric Cancer.敲低RIPK2可抑制胃癌中NF-κB信号通路的增殖和迁移,并诱导细胞凋亡。
Front Genet. 2021 Feb 9;12:627464. doi: 10.3389/fgene.2021.627464. eCollection 2021.
2
MicroRNA negatively regulates NF-κB-mediated immune responses by targeting NOD1 in the teleost fish Miichthys miiuy.微小RNA通过靶向鲻鱼中的NOD1负调控NF-κB介导的免疫反应。
Sci China Life Sci. 2021 May;64(5):803-815. doi: 10.1007/s11427-020-1777-y. Epub 2020 Aug 17.
3
AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes.
Receptor interacting serine/threonine kinase 2 promotes rheumatoid arthritis progression and partially regulates nuclear factor kappa B pathway.
受体相互作用丝氨酸/苏氨酸激酶2促进类风湿关节炎进展并部分调节核因子κB通路。
Cytojournal. 2024 Nov 27;21:56. doi: 10.25259/Cytojournal_63_2024. eCollection 2024.
4
Silencing CCT3 induces ferroptosis through the NOD1-NF-κB signaling pathway in bladder cancer.沉默 CCT3 通过 NOD1-NF-κB 信号通路诱导膀胱癌中的铁死亡。
Sci Rep. 2024 Oct 31;14(1):26188. doi: 10.1038/s41598-024-76724-z.
5
NOD1 and NOD2: Essential Monitoring Partners in the Innate Immune System.NOD1和NOD2:先天免疫系统中至关重要的监测伙伴。
Curr Issues Mol Biol. 2024 Aug 28;46(9):9463-9479. doi: 10.3390/cimb46090561.
6
Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning.利用基因表达数据和机器学习评估卵巢癌化疗反应
BioMedInformatics. 2024 Jun;4(2):1396-1424. doi: 10.3390/biomedinformatics4020077. Epub 2024 May 22.
7
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1.产肠毒素脆弱拟杆菌菌毛蛋白 BFT-1 通过其功能受体 NOD1 促进乳腺癌细胞干性和化疗耐药性
Protein Cell. 2024 May 28;15(6):419-440. doi: 10.1093/procel/pwae005.
8
The impact of apelin-13 on cisplatin-induced endocrine pancreas damage in rats: an in vivo study.阿利肽-13 对顺铂诱导的大鼠内分泌胰腺损伤的影响:一项体内研究。
Histochem Cell Biol. 2024 May;161(5):391-408. doi: 10.1007/s00418-024-02269-x. Epub 2024 Feb 18.
9
Investigation into the Role of Long-Non-Coding RNA in Leukemia.长链非编码RNA在白血病中的作用研究
Noncoding RNA. 2023 Aug 11;9(4):47. doi: 10.3390/ncrna9040047.
10
RIPK2: a promising target for cancer treatment.RIPK2:一种有前景的癌症治疗靶点。
Front Pharmacol. 2023 May 30;14:1192970. doi: 10.3389/fphar.2023.1192970. eCollection 2023.
AGER1 下调与非酒精性脂肪性肝炎和 2 型糖尿病的纤维化有关。
J Clin Invest. 2020 Aug 3;130(8):4320-4330. doi: 10.1172/JCI133051.
4
Activation of the pattern recognition receptor NOD1 augments colon cancer metastasis.模式识别受体 NOD1 的激活增强结肠癌转移。
Protein Cell. 2020 Mar;11(3):187-201. doi: 10.1007/s13238-019-00687-5. Epub 2020 Jan 19.
5
NOD1 inhibits proliferation and enhances response to chemotherapy via suppressing SRC-MAPK pathway in hepatocellular carcinoma.NOD1 通过抑制 SRC-MAPK 通路抑制肝癌细胞增殖并增强化疗反应。
J Mol Med (Berl). 2020 Feb;98(2):221-232. doi: 10.1007/s00109-019-01868-9. Epub 2019 Dec 23.
6
Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway.环氧化酶 2 通过 PGE2/NF-κB 通路促进卵巢癌细胞的增殖和侵袭。
Cell Transplant. 2019 Dec;28(1_suppl):1S-13S. doi: 10.1177/0963689719890597. Epub 2019 Dec 10.
7
Ovarian cancer: Current status and strategies for improving therapeutic outcomes.卵巢癌:改善治疗效果的现状和策略。
Cancer Med. 2019 Nov;8(16):7018-7031. doi: 10.1002/cam4.2560. Epub 2019 Sep 27.
8
NOD1 and NOD2 of the innate immune system is differently expressed in human clear cell renal cell carcinoma, corresponding healthy renal tissue, its vasculature and primary isolated renal tubular epithelial cells.固有免疫系统中的 NOD1 和 NOD2 在人透明细胞肾细胞癌、相应的健康肾组织、其血管和原发性分离的肾小管上皮细胞中表达不同。
J Cancer Res Clin Oncol. 2019 Jun;145(6):1405-1416. doi: 10.1007/s00432-019-02901-7. Epub 2019 Mar 22.
9
Synthesis, Characterization, and Bacterial Fouling-Resistance Properties of Polyethylene Glycol-Grafted Polyurethane Elastomers.聚乙二醇接枝聚氨酯弹性体的合成、表征及抗细菌污染性能。
Int J Mol Sci. 2019 Feb 25;20(4):1001. doi: 10.3390/ijms20041001.
10
NOD1: An Interface Between Innate Immunity and Insulin Resistance.NOD1:固有免疫与胰岛素抵抗的交汇点。
Endocrinology. 2019 May 1;160(5):1021-1030. doi: 10.1210/en.2018-01061.